Business Wire – n-Lorem

n-Lorem Publishes Recommendations for Treating Patients with Heterozygous Toxic Gain of Function Mutations

Article published in Nucleic [...]

Andrew Andrew Serrano2024-10-03T11:00:56-04:00

Positive Clinical Observations from n-Lorem Treated, KIF1A Nano-rare Patient Published in Nature Medicine

Case study, published in [...]

Andrew Andrew Serrano2024-08-09T16:11:11-04:00

n-Lorem Foundation Names Andrew W. Lo as a New Member of its Board of Directors

Andrew Lo’s expertise in [...]

Andrew Andrew Serrano2024-08-13T21:09:50-04:00

n-Lorem Foundation Welcomes New Member Alan Lotvin to its Board of Directors

Alan Lotvin’s expertise in [...]

Andrew Andrew Serrano2024-08-13T21:09:24-04:00

n-Lorem Foundation Partners with Hongene Biotech Corporation to Support the Discovery of Personalized ASO Medicines for Nano-rare Patients

SAN DIEGO, Calif., [...]

Andrew Andrew Serrano2024-08-26T21:00:19-04:00

n-Lorem Foundation Collaborates with Across Healthcare to Develop a Custom Submission Platform for Physicians of Nano-rare Patients

SAN DIEGO, Calif., [...]

Andrew Andrew Serrano2024-05-13T22:32:52-04:00

n-Lorem Foundation Announces the Second Annual Nano-rare Patient Colloquium Will be Held on Oct. 30 & 31, 2024

This year’s colloquium will [...]

Andrew Andrew Serrano2024-05-08T23:05:52-04:00

n-Lorem Provides Update on Its Remarkable Progress to Deliver Hope and Potential Help to More Than 100 Nano-rare Patients

n-Lorem delivers on its [...]

Andrew Andrew Serrano2024-04-23T19:33:39-04:00

n-Lorem Unveils Limited Edition Holiday Ornament to Support its Mission to Provide Optimized ASO Therapies to Nano-rare Patients For Free, For Life

Please consider supporting nano-rare [...]

Andrew Andrew Serrano2024-04-15T20:15:31-04:00

n-Lorem Foundation Founder and CEO, Stanley Crooke, Named One of San Diego’s Most Influential People by the San Diego Business Journal

The San Diego Business [...]

Andrew Andrew Serrano2024-04-09T23:06:51-04:00